To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.
Find out MoreSyncona Share Price | |
---|---|
Price | 125.40 |
Bid | 0.00 |
Ask | 0.00 |
Change | 0.00 (0.00%) |
Volume | 0 |
Open | 0.00 |
High | 0.00 |
Low | 0.00 |
Prev. Close | 125.40 |
Currency | GBX |
---|---|
Issue Country | GG |
Shares in Issue | 652.76m |
Market Capitalisation | £818.56m |
Market Size | 5,000 |
52 Week High | 162.20 |
52 Week High Date | 24-May-2023 |
52 Week Low | 105.00 |
52 Week Low Date | 28-Sep-2023 |
# Trades | 0 |
---|---|
Vol. Sold | 0 |
Sold Value | £N/A |
Vol. Bought | 0 |
Bought Value | £N/A |
PE Ratio | -14.9642 |
Earnings | -8.38 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
30-Apr-24 | 16:35:28 | 125.40 | 78,420 | Buy* | 125.00 | 125.60 | 98.34k | UT Uncrossing Trade |
30-Apr-24 | 16:24:55 | 125.60 | 89 | Buy* | 125.20 | 125.60 | 111.78 | A Automatic Execution |
30-Apr-24 | 16:24:29 | 125.60 | 312 | Buy* | 125.20 | 125.60 | 391.87 | A Automatic Execution |
30-Apr-24 | 16:22:59 | 125.60 | 33 | Buy* | 125.20 | 125.60 | 41.45 | A Automatic Execution |
30-Apr-24 | 16:22:59 | 125.60 | 276 | Buy* | 125.20 | 125.60 | 346.66 | A Automatic Execution |
30-Apr-24 | 16:22:59 | 125.60 | 350 | Buy* | 125.20 | 125.60 | 439.60 | A Automatic Execution |
30-Apr-24 | 16:22:59 | 125.60 | 332 | Buy* | 125.20 | 125.60 | 416.99 | A Automatic Execution |
30-Apr-24 | 16:22:50 | 125.20 | 20 | Sell* | 125.20 | 125.60 | 25.04 | A Automatic Execution |
30-Apr-24 | 16:22:50 | 125.60 | 27 | Buy* | 125.20 | 125.60 | 33.91 | A Automatic Execution |
30-Apr-24 | 16:22:49 | 125.60 | 834 | Buy* | 125.20 | 125.60 | 1,048 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
09-Mar-22 | 09-Mar-22 | Buy | Robert Hutchinson held the position of Independent Non-Executive Director at the time of this trade.Robert Hutchinson | 171.80 | GBX | 26,000 | 94,827 |
12-May-21 | 10-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 222.12 | GBX | 639,885 | 2,000,000 |
12-May-21 | 10-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 223.88 | GBX | 3,222,943 | 2,000,000 |
12-May-21 | 11-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 202.05 | GBX | 2,137,172 | 2,000,000 |
06-Apr-21 | 01-Apr-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 250.01 | GBX | 317,961 | 2,000,000 |
We are focused on maximising value at all points of the investment cycle to deliver transformational treatments to patients